What Is Injectable HIV PrEP? The US Food and Drug Administration (FDA) has approved one injectable pre-exposure prophylaxis (PrEP) medication: cabotegravir (CAB) 600 mg (brand …

Sep 18, 2025 · PrEP, or pre-exposure prophylaxis, is medicine people at risk for HIV take to prevent getting HIV from sex or injection drug use. PrEP can stop HIV from taking hold and …

This page includes implementation information for both formulations of long-acting injectable PrEP, cabotegravir (Apretude) and lenacapavir (Yeztugo), including frequently asked …

Jul 3, 2025 · The U.S. Food and Drug Administration (FDA) has approved two HIV PrEP pills (Truvada and Descovy) and two long-acting injectable PrEP medicines (Apretude and …

How PrEP Works and Who It’s For PrEP, which stands for Pre‑Exposure Prophylaxis, is one of the most talked‑about HIV prevention options because of its high effectiveness when taken …

Lenacapavir: (injectable PrEP) The injection site reactions: Headache and nausea Reactions at the injection site: lump or bump pain skin hardening swelling itching redness bruising warmth …

Jun 18, 2025 · Yeztugo (lenacapavir) injection, 463.5 mg/1.5 mL, is indicated for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents …

Apr 15, 2025 · The introduction of long-acting injectable PrEP, whether in the form of cabotegravir or lenacapavir, represents a significant step forward in HIV prevention. For patients who …

Jul 14, 2025 · The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre …

Feb 10, 2025 · PrEP (pre-exposure prophylaxis) is the use of antiretroviral medication to prevent HIV. PrEP is for people without HIV who may be exposed to HIV through sex or injection drug …